glp-1 receptor agonist: Frontiers

Understanding the Difference: While both peptides are powerful metabolic tools, their pharmacology is distinct: Tirzepatide (Manjaro): This is a dual agonist targeting GLP-1 (Glucagon-like peptide-1) and GIP (Glucose-dependent insulinotropic ...

GLP-1 Receptor Agonists for Kidney Transplant Patients | Tarek Abbas posted on the topic | LinkedIn

Most people think all GLP-1 medications are basically the same. They're not. Ozempic. Wegovy. Mounjaro. Zepbound. Different approvals. Different dosing. Different weight-loss outcomes. Different side-effect profiles. The best one isn't the most

Insight into Structure Activity Relationship of DPP-4 Inhibitors for Development of Antidiabetic Agents

This randomized clinical trial evaluated the risk of clinically significant residual gastric volume in adults undergoing elective upper endoscopy while receiving glucagon-like peptide-1 (#GLP1) or glucose-dependent insulinotropic polypeptide (GIP ...

Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society -